Clinical Trial Update: Utilizing the Crosstalk Among Chicoric Acid, 13-Cis Retinoic Acid(Aerosolized), Minocycline and Vitamin D as a Potent Quadrate Therapy for Treating Patients With Multidrug-resistant TB and Patient With Both Multidrug-resistant TB and COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating a combination therapy (chicoric acid, 13-cis retinoic acid aerosolized, minocycline, and vitamin D) for multidrug-resistant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• 13-Cis Retinoic Acid (Aerosolized) (13-cis retinoic acid)
• Minocycline (minocycline)
• Vitamin D (Cholecalciferol)
• chicoric acid

Snippet

Sponsor: Kafrelsheikh University | Conditions: Tuberculosis | Phase 2 | Status: UNKNOWN